Glazer Capital LLC’s ZyVersa Therapeutics ZVSA Stock Holding History

Glazer Capital LLC’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-265	Closed	-$926K	–	522
2022 Q3	$926K	Buy	265 +26	+11%	+$90.8K	0.02%	367
2022 Q2	$832K	Buy	239 +36	+18%	+$125K	0.02%	395
2022 Q1	$701K	Buy	+203	New	+$702K	0.02%	344

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Glazer Capital LLC's ZVSA Position: Q4 2022 in Review

Glazer Capital LLC sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 265 shares — an estimated $926K sold.

Glazer Capital LLC first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $926K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Glazer Capital LLC reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 265 ZyVersa Therapeutics shares in Q4 2022, an estimated $926K.
Glazer Capital LLC first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
Glazer Capital LLC's ZyVersa Therapeutics position peaked at $926K in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.